MedTrace Logo

Anxiety Disorders in Children - Association With Neurodevelopmental Delay/Disorder

NCT00553085 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 141

Last updated 2014-06-20

No results posted yet for this study

Summary

The main objective of the study is to examine the relationship between anxiety disorders and neurodevelopmental disorder/delay in children aged 7- 13 years.

Conditions

  • Anxiety Disorders

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER

  • University Hospital, Akershus

    collaborator OTHER

  • Lovisenberg Diakonale Hospital

    collaborator OTHER

  • The Hospital for Sick Children

    collaborator OTHER

  • Regionsenter for barn og unges psykiske helse

    lead OTHER

Principal Investigators

  • Hanne Kristensen, Ph.D. · Regionsenter for barn og unges psykiske helse

Eligibility

Min Age
7 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2009-12-31
Completion
2014-03-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00553085 on ClinicalTrials.gov